Reactivity of engineered inorganic nanoparticles and carbon nanostructures in biological media

Nanotoxicology

Volumn 2, Issue 3, 2008, Pages 99-112

  Bastús, Neus G ^a   Casals, Eudald ^a   Vázquez Campos, Socorro ^a   Puntes, Victor ^a,b  

^a CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Nanoparticles; Nanotoxicology; Surface chemistry

Indexed keywords

CARBON; NANOMATERIAL; NANOPARTICLE;

BIOCOMPATIBILITY; BIODEGRADATION; HEALTH HAZARD; INFLAMMATION; NANOENGINEERING; NANOTECHNOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 49549111370     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390802217830     Document Type: Review

References (128)

1. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617-12621.
2. Alivisatos AP. 2001. Less is more in medicine - sophisticated forms of nanotechnology will find some of their first real-world applications in biomedical research, disease diagnosis and, possibly, therapy. Scientific American 285:66-73.
3. Alivisatos P. 2004. The use of nanocrystals in biological detection. Nature Biotechnol 22:47-52.
4. Bhattacharya R, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D. 2004. Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano Lett 4:2479-2481.
5. Blakemore R. 1975. Magnetotactic bacteria. Science 190:377-379.
6. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicological Sci 88:412-419.
7. Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fievet F. 2006. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 6:866-870.
8. Brown DM, Stone V, Findlay P, MacNee W, Donaldson K. 2000. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occupat Environ Med 57:685-691.
9. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191-199.
10. Brown GE, Henrich VE, Casey WH, Clark DL, Eggleston C, Felmy A, et al. 1999. Metal oxide surfaces and their interactions with aqueous solutions and microbial organisms. Chem Rev 99:77-174.
11. Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP. 1998. Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013-2016.
12. Cedervall T, Lynch I, Foy M, Berggad T, Donnelly SC, Cagney G, et al. 2007a. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angewandte Chemie - Int Ed 46:5754-5756.
13. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. 2007b. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050-2055.
14. Colvin VL. 2003. The potential environmental impact of engineered nanomaterials. Nature Biotechnol 21:1166-1170.
15. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325-327.
16. Cyrys J, Stolzel M, Heinrich J, Kreyling WG, Menzel N, Wittmaack K, et al. 2003. Elemental composition and sources of fine and ultrafine ambient particles in Erfurt, Germany. Sci Total Environ 305:143-156.
17. Chah S, Hammond MR, Zare RN. 2005. Gold nanoparticles as a colorimetric sensor for protein conformational changes. Chem Biol 12:323-328.
18. Cheng YS, Zhou Y, Irvin CM, Pierce RH, Naar J, Backer LC, et al. 2005. Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ Health Perspect 113:638-643.
19. Chithrani BD, Ghazani AA, Chan WCW. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662-668.
20. Daniel MC, Astruc D. 2004. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104:293-346.
21. de Lorenzo AJ. 1970. The olfactory neuron and the blood-brain barrier. In: Wolstenholme G, Knight J, editors. Taste and smell in vertebrates. London, UK: Churchill. pp 151-176.
22. Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11-18.
23. DeVries GA, Brunnbauer M, Hu Y, Jackson AM, Long B, Neltner BT, et al. 2007. Divalent metal nanoparticles. Science 315:358-361.
24. Ding LH, Stilwell J, Zhang TT, Elboudwarej O, Jiang HJ, Selegue JP, et al. 2005. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 5:2448-2464.
25. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, et al. 2002. The pulmonary toxicology of ultrafine particles. J Aerosol Med - Deposition Clearance and Effects in the Lung 15:213-220.
26. Donaldson K, Li XY, Macnee W. 1998. Ultrafine (nanometre) particle mediated lung injury. J Aerosol Sci 29:553-560.
27. Donlin MJ, Frey RF, Putnam C, Proctor JK, Bashkin JK. 1998. Analysis of iron in ferritin, the iron-storage protein - a general chemistry experiment. J Chem Educ 75:437-441.
28. Driscoll KE. 1996. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhalat Toxicol 8(suppl.):139-153.
29. Dunford R, Salinaro A, Cai LZ, Serpone N, Horikoshi S, Hidaka H, et al. 1997. Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients. FEBS Lett 418:87-90.
30. El-Sayed IH, Huang XH, El-Sayed MA. 2006. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 239:129-135.
31. Evelyn A, Mannick S, Sermon PA. 2003. Unusual carbon-based nanofibers and chains among diesel-emitted particles. Nano Lett 3:63-64.
32. Farokhzad OC, Cheng JJ, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. 2006. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103:6315-6320.
33. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, et al. 2002. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Communic 294:116-119.
34. Freitas RAJ. 1999. Nanomedicine. Vol. I: Basic capabilities. Georgetown, TX: Landes Bioscience.
35. Gallego O, Puntes V. 2006. What can nanotechnology do to fight cancer? Clin Transl Oncol 8:788-95.
36. Gider S, Awschalom DD, Douglas T, Mann S, Chaparala M. 1995. Classical and quantum magnetic phenomena in natural and artificial ferritin proteins. Science 268:77-80.
37. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. 2007. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ Health Perspect 115:403-409.
38. Gopinath PG, Gopinath G, Kumar TCA. 1978. Target site of intranasally sprayed substances and their transport across nasal-mucosa - new insight into intranasal route of drugdelivery. Curr Therap Res - Clin Experimental 23:596-607.
39. Goyer RA. 1995. Nutrition and metal toxicity. Am J Clin Nutrit 61:S646-650.
40. Greim H, Borm P, Schins R, Donaldson K, Driscoll K, Hartwig A, et al. 2001. Toxicity of fibers and particles - report of the workshop held in Munich, Germany, 26-27 October 2000. Inhalat Toxicol 13:737-754.
41. Gupta AK, Gupta M. 2005. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26:1565-1573.
42. Hidaka H, Horikoshi S, Serpone N, Knowland J. 1997. In vitro photochemical damage to DNA, RNA and their bases by an inorganic sunscreen agent on exposure to UVA and UVB radiation. J Photochem Photobiol A-Chem 111:205-213.
43. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki YF, Ohta T, et al. 2004. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4:2163-2169.
44. Hughes LS, Cass GR, Gone J, Ames M, Olmez I. 1998. Physical and chemical characterization of atmospheric ultrafine particles in the Los Angeles area. Environ Sci Technol 32:1153-1161.
45. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in Vitro 19:975-983.
46. Hvolbaek B, Janssens TVW, Clausen BS, Falsig H, Christensen CH, Norskov JK. 2007. Catalytic activity of Au nanoparticles. Nano Today 2:14-18.
47. Hyung H, Fortner JD, Hughes JB, Kim JH. 2007. Natural organic matter stabilizes carbon nanotubes in the aqueous phase. Environ Sci Technol 41:179-184.
48. Jackson AM, Myerson JW, Stellacci F. 2004. Spontaneous assembly of subnanometre-ordered domains in the ligand shell of monolayer-protected nanoparticles. Nature Materials 3:330-336.
49. Jana NR, Gearheart L, Murphy CJ. 2001. Seeding growth for size control of 5-40 nm diameter gold nanoparticles. Langmuir 17:6782-6786.
50. Johnston CJ, Finkelstein JN, Mercer P, Corson N, Gelein R, Oberdorster G. 2000. Pulmonary effects induced by ultrafine PTFE particles. Toxicol Appl Pharmacol 168:208-215.
51. Joo SH, Feitz AJ, Waite TD. 2004. Oxidative degradation of the carbothioate herbicide, molinate, using nanoscale zero-valent iron. Environ Sci & Technol 38(7):2242-2247.
52. Kalambur VS, Han B, Hammer BE, Shield TW, Bischof JC. 2005. In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical applications. Nanotechnology 16:1221-1233.
53. Kan AT, Tomson MB. 1990. Ground-water transport of hydrophobic organic-compounds in the presence of dissolved organic-matter. Environ Toxicol Chem 9:253-263.
54. Kersting AB, Efurd DW, Finnegan DL, Rokop DJ, Smith DK, Thompson JL. 1999. Migration of plutonium in ground water at the Nevada Test Site. Nature 397:56-59.
55. Kirchner C, Liedl T, Kudera S, Pellegrino T, Javier AM, Gaub HE, et al. 2005. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 5:331-338.
56. Kirschvink JL, Walker MM, Diebel CE. 2001. Magnetite-based magnetoreception. Curr Opin Neurobiol 11:462-467.
57. Kogan MJ, Bastus NG, Amigo R, Grillo-Bosch D, Araya E, Turiel A, et al. 2006. Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett 6:110-115.
58. Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65-81.
59. Kulmala M, Vehkamaki H, Petajda T, Dal Maso M, Lauri A, Kerminen VM, et al. 2004. Formation and growth rates of ultrafine atmospheric particles: A review of observations. J Aerosol Sci 35:143-176.
60. Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. 2005. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect 113:201-206.
61. Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological Sci 77:126-134.
62. Lazaro FJ, Abadia AR, Romero MS, Gutierrez L, Lazaro J, Morales MP. 2005. Magnetic characterisation of rat muscle tissues after subcutaneous iron dextran injection. Biochimica et Biophysica Acta-Molec Basis of Dis 1740:434-445.
63. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. 2003. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111:455-460.
64. Liopo AV, Stewart MP, Hudson J, Tour JM, Pappas TC. 2006. Biocompatibility of native and functionalized single-walled carbon nanotubes for neuronal interface. J Nanosci Nanotechnol 6:1365-1374.
65. Maeda H. 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189-207.
66. Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW, Celio M, et al. 2006. Cellular toxicity of carbon-based nanomaterials. Nano Lett 6:1121-1125.
67. Margeat O, Ciuculescu D, Lecante P, Respaud M, Amiens C, Chaudret B. 2007. NiFe nanoparticles: A soft magnetic material? Small 3:451-458.
68. Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer-chemotherapy - mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387-6392.
69. Matsunaga T, Sakaguchi T. 2000. Molecular mechanism of magnet formation in bacteria. J Biosci Bioengineering 90:1-13.
70. Matsunaga T, Togo H, Kikuchi T, Tanaka T. 2000. Production of luciferase-magnetic particle complex by recombinant Magnetospirillum sp AMB-1. Biotechnol Bioengineering 70:704-709.
71. Medalia O, Weber I, Frangakis AS, Nicastro D, Gerisch G, Baumeister W. 2002. Macromolecular architecture in eukaryotic cells visualized by cryoelectron tomography. Science 298:1209-1213.
72. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YYY, Riviere JE. 2005. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 155:377-384.
73. Murday J S. 2002. The coming revolution: science and technology of nanoscale structures. The AMPTIAC Newsl 6:5-10.
74. Murr LE, Esquivel EV, Bang JJ. 2004. Characterization of nanostructure phenomena in airborne particulate aggregates and their potential for respiratory health effects. J Mater Sci Mater Med 15:237-47.
75. Murugesan S, Park TJ, Yang HC, Mousa S, Linhardt RJ. 2006. Blood compatible carbon nanotubes - nano-based neoproteoglycans. Langmuir 22:3461-3463.
76. 2. Environ Sci Technol 38:1600-1604.
77. Nath N, Chilkoti A. 2001. Interfacial phase transition of an environmentally responsive elastin biopolymer adsorbed on functionalized gold nanoparticles studied by colloidal surface plasmon resonance. J Am Chem Soc 123:8197-8202.
78. Nikoobakht B, El-Sayed MA. 2003. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem Materials 15:1957-1962.
79. National Nanotechnology Initiative (NNI) 2004. What is nanotechnology? Accessed from the internet website: http://www.nano.gov/html/facts/whatIsNano. html.
80. National Research Council (NRC). 1983. Risk assessment in the Federal Government: managing the process. Washington DC, US: National Academy Press.
81. O'Dowd CD, Facchini MC, Cavalli F, Ceburnis D, Mircea M, Decesari S, et al. 2004. Biogenically driven organic contribution to marine aerosol. Nature 431:676-680.
82. Oberdörster E. 2004. Manufactured nanomaterials (Fullerenes, C-60) induce oxidative stress in the brain of juvenile large-mouth bass. Environ Health Perspect 112:1058-1062.
83. Oberdörster G. 2000. Toxicology of ultrafine particles: in vivo studies. Philosoph Transact Roy Soc London Series A - Math Phys Engineering Sci 358:2719-2739.
84. Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992. Role of the alveolar macrophage in lung injury - studies with ultrafine particles. Environ Health Perspect 97:193-199.
85. Oberdörster G, Finkelstein J, Johnston C, Gelein R, Cox C, Baggs R, et al. 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 96:5-74.
86. Oberdörster G, Oberdörster E, Oberdorster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
87. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, et al. 2004. Translocation of inhaled ultrafine particles to the brain. Inhalat Toxicol 16:437-445.
88. Oberdörster G, Yu CP. 1990. The carcinogenic potential of inhaled diesel exhaust - a particle effect. J Aerosol Sci 21:S397-401.
89. Okamura Y, Takeyama H, Matsunaga T. 2000. Two-dimensional analysis of proteins specific to the bacterial magnetic particle membrane from Magnetospirillum sp AMB-1. Appl Biochem Biotechnol 84-6:441-446.
90. Okuhata Y. 1999. Delivery of diagnostic agents for magnetic resonance imaging. Adv Drug Deliv Rev 37:121-137.
91. Pal S, Tak YK, Song JM. 2007. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712-1720.
92. Peng XG, Manna L, Yang WD, Wickham J, Scher E, Kadavanich A, et al. 2000. Shape control of CdSe nanocrystals. Nature 404:59-61.
93. Penn SG, He L, Natan MJ. 2003. Nanoparticles for bioanalysis. Curr Opin Chem Biol 7:609-615.
94. Pernodet N, Fang XH, Sun Y, Bakhtina A, Ramakrishnan A, Sokolov J, et al. 2006. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2:766-773.
95. Puntes VF, Krishnan KM, Alivisatos AP. 2001. Colloidal nanocrystal shape and size control: The case of cobalt. Science 291:2115-2117.
96. Puntes VF, Zanchet D, Erdonmez CK, Alivisatos AP. 2002. Synthesis of hcp-Co nanodisks. J Am Chem Soc 124:12874-12880.
97. Rancan F, Rosan S, Boehm F, Cantrell A, Brellreich M, Schoenberger H, et al. 2002. Cytotoxicity and photocytotoxicity of a dendritic C-60 mono-adduct and a malonic acid C-60 tris-adduct on Jurkat cells. J Photochem Photobiol B-Biol 67:157-162.
98. Ren L, Chow GM. 2003. Synthesis of nir-sensitive Au-Au2S nanocolloids for drug delivery. Mater Sci Engineering C-Biomimetic Supramolec Syst 23:113-116.
99. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, Mirkin CA. 2006. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312:1027-1030.
100. Roucoux A, Schulz J, Patin H. 2002. Reduced transition metal colloids: A novel family of reusable catalysts? Chem Rev 102:3757-3778.
101. Sakurai T, Kaise T, Matsubara C. 1998. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem Res Toxicol 11:273-283.
102. Savic R, Luo LB, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615-618.
103. Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, et al. 2004. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 4:1881-1887.
104. Seifert G. 2004. Nanomaterials - nanocluster magic. Nature Materials 3:77-78.
105. Sengupta S, Eavarone D, Capila I, Zhao GL, Watson N, Kiziltepe T, et al. 2005. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436:568-572.
106. Serpone N, Salinaro A, Emeline A. 2001. Deleterious effects of sunscreen titanium dioxide nanoparticles on DNA: Efforts to limit DNA damage by particle surface modification. Proc SPIE 4258:86-98.
107. Service RF. 2000. Is nanotechnology dangerous? Science 290:1526-1527.
108. Service RF. 2005. Nanotechnology takes aim at cancer. Science 310:1132-1134.
109. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. 2005. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21:10644-10654.
110. Shvedova AA, Kisin E, Keshava N, Murray AR, Gorelik O, Arepalli S, et al. 2004a. Cytotoxic and genotoxic effects of single wall carbon nanotube exposure on human keratinocytes and bronchial epithelial cells. Abstracts of Papers Am Chem Soc 227:U1233-1233.
111. Shvedova AA, Kisin E, Murray A, Schwegler-Berry D, Gandelsman V, Baron P, et al. 2004b. Exposure of human bronchial cells to carbon nanotubes caused oxidative stress and cytotoxicity. Proc Meeting of the SFRR Eur (June 26-29, 2003).
112. Stone V, Donaldson K. 2006. Nanotoxicology-Signs of stress. Nature Nanotechnology 1:23-24.
113. Suehiro T, Hirosaki N, Komeya K. 2003. Synthesis and sintering properties of aluminium nitride nanopowder prepared by the gas-reduction-nitridation method. Nanotechnology 14:487-491.
114. Tang J, Myers M, Bosnick KA, Brus LE. 2003. Magnetite Fe3O4 nanocrystals: Spectroscopic observation of aqueous oxidation kinetics. J Phys Chem B 107:7501-7506.
115. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. 2000. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhalat Toxicol 12:1113-1126.
116. Tran CL, Jones AD, Cullen RT, Donaldson K. 1998. Influence of particle characteristics on the clearance of low toxicity dusts from lungs. J Aerosol Sci 29(suppl.):S1269-1270.
117. Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G, et al. 2005. Cellular uptake and toxicity of AU(55) clusters. Small 1:841-844.
118. US Environmental Protection Agency (US EPA). 2004. Air quality criteria for particulate matter. Washington DC, US: EPA.
119. Viswanathan G, Murugesan S, Pushparaj V, Nalamasu O, Ajayan PM, Linhardt RJ. 2006. Preparation of biopolymer fibers by electrospinning from room temperature ionic liquids. Biomacromolecules 7:415-418.
120. Walter P, Welcomme E, Hallegot P, Zaluzec NJ, Deeb C, Castaing J, et al. 2006. Early Use of PbS Nanotechnology for an Ancient Hair Dyeing Formula. Nano Lett. 6(10):2215-2219.
121. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GAM, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77:117-125.
122. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, et al. 1989. superparamagnetic iron-oxide - pharmacokinetics and toxicity. Am J Roentgenol 152:167-173.
123. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. 2002. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 184:172-179.
124. Woehrle GH, Brown LO, Hutchison JE. 2005. Thiol-functionalized, 1.5-nm gold nanoparticles through ligand exchange reactions: Scope and mechanism of ligand exchange. J Am Chem Soc 127:2172-2183.
125. Worle-Knirsch JM, Pulskamp K, Krug HF. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 6:1261-1268.
126. Yamakoshi Y, Umezawa N, Ryu A, Arakane K, Miyata N, Goda Y, et al. 2003. Active oxygen species generated from photoexcited fullerene (C-60) as potential medicines: O-2(-center dot) versus O-1(2). J Am Chem Soc 125:12803-12809.
127. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. 1995. Vascular-permeability in a human tumor xenograft - molecular-size dependence and cutoff size. Cancer Res 55:3752-3756.
128. Zhang DH, Kandadai MA, Cech J, Roth S, Curran SA. 2006. Poly(L-lactide) (PLLA)/multiwalled carbon nanotube (MWCNT) composite: Characterization and biocompatibility evaluation. J Phys Chem B 110:12910-12915.